Headlines Covid-19 Specialties Trending Feeds Videos

Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination | NEJM

posted 2 weeks


Mashup Score: 529

New England Journal of Medicine (NEJM) - Clinical Decisions from The New England Journal of Medicine — Delayed Second Dose versus Standard Regimen for Covid-19...

TCT Meetings - 2021 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - Graft versus host disease (GVHD) is the leading cause of non-relapse mortality...

Symplur - The TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (TCT Meetings) are the combined annual meetings of the American Society...

American Society of Hematology Publications - Key Points. With sufficient resources, HSCT can safely continue in the COVID-19 pandemic if primary responsibility for COVID-19 patients is not...

TCT Meetings - 2021 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - Introduction Monoclonal antibody (mAb)-targeting of CD117 (c-Kit) present on...

Sickle Cell Disease: What’s New with Transplant and Gene Therapy?

posted 3 days


Mashup Score: 4

www.stjude.org - This virtual symposium will discuss hematopoietic stem cell transplantation (HSCT) and gene therapy (GT) for sickle cell disease, with a focus on topics such...

TCT Meetings - 2021 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - Introduction: The standard dose (50 mg/kg/day) and timing (days +3/+4) of PTCy...

Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines | CDC

posted 3 weeks


Mashup Score: 2

Centers for Disease Control and Prevention - Find interim clinical considerations for the use of mRNA COVID-19...

  • 🚨New guidance from @CDCgov for persons exposed to someone with #COVID19 🚨 Quarantine NOT required if: 1. Fully vaccinated  ( ≥ 2 wks s/p 2nd dose of 2-dose vaccine or ≥ 2 wks s/p single dose vaccine) 2. Within 3 months of last dose 3. Asymptomatic https://t.co/076FDN7YMb

Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis

posted 2 weeks


Mashup Score: 2

OUP Academic - In this retrospective study of adult patients hospitalized with COVID-19, tocilizumab was associated with a 62% reduction in hazard of death. Tocilizumab may...

  • Tocilizumab may provide benefit in a subgroup of patients hospitalized with #COVID19 who have elevated biomarkers of hyperinflammation, without increasing the risk of secondary infection. https://t.co/kdj8qgl1RJ

TCT Meetings - 2021 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR - Background. In vivo hematopoietic stem cell (HSC) gene therapy represents a...